University of Tasmania
Browse

File(s) under permanent embargo

Therapy development for the lysosomal storage disease Fucosidosis using the canine animal model

journal contribution
posted on 2023-05-21, 03:15 authored by Jessica FletcherJessica Fletcher, Taylor, RM
Abstract Fucosidosis (OMIM 23000) is an inherited neurodegenerative lysosomal storage disease caused by a deficiency of the lysosomal hydrolase a-L-fucosidase due to mutations in the FUCA1 gene. Without enzyme-targeted therapy patients rarely survive beyond the first decade of life, and therapy options other than supportive care are limited. Hematopoietic transplants, first developed in the fucosidosis dog model, are the only treatment option available capable of delaying the disease course. However, due to the risks and exclusion criteria of this treatment additional therapies are required. The development of additional therapies including intravenous and intra-cerebrospinal fluid enzyme replacement therapy and gene therapy, which have been trialed in the canine model, will be discussed.

History

Publication title

Pediatric Endocrinology Reviews

Volume

13

Issue

Suppl 1

Pagination

602-611

ISSN

1565-4753

Department/School

Menzies Institute for Medical Research

Publisher

Y.S. Medical Media Ltd.

Place of publication

Israel

Rights statement

© 2017 by MEDICALMEDIA for PER Pediatric Endocrinology Reviews. All rights reserved

Repository Status

  • Restricted

Socio-economic Objectives

Expanding knowledge in the biomedical and clinical sciences

Usage metrics

    University Of Tasmania

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC